Xap Therapeutics is a start-up biotechnology company that is developing an innovative, synthetic biology-driven platform for cell therapeutics.Xap Therapeutics, formed by biotech entrepreneurs, is a producer of a "chassis" cell which functions in cell therapies through genetically engineered constructs. Xap Therapeutics wasestablished in 2017 by James Patterson, M.D., Ph.D in Cambridge, England.

Biotechnology

Health Care

Health Diagnostics

Xap Therapeutics

Xap Therapeutics' headquarters in Cambridge, United Kingdom

Louis H.

Carly Kempster

Miriam Mendez Tavio

Laurent Jespers

Josie Stevens

Shaun Foy

James Patterson

313 nguyencong_minhduc

Tongtong Zhao

Aurore Saudemont

Juan-Jose Guijarro-Leach

Sandra Van Wetering

The Research and Development team at Xap Therapeutics focuses on pioneering advancements in cell therapeutics using synthetic biology. This team is responsible for designing, developing, and optimizing genetically engineered "chassis" cells that serve as the foundation for innovative cell therapy treatments. Their work includes upstream research, cell line engineering, and continuous improvement of platform technologies to revolutionize therapeutic outcomes.

Research and Development

The Leadership Team at Xap Therapeutics is responsible for guiding the strategic direction and operational oversight of the company. Comprising experts in scientific research, finance, and executive management, the team collaborates to drive innovation in cell therapeutics, ensure efficient allocation of resources, and foster growth to achieve the company's mission of developing advanced synthetic biology-driven cell therapies.

Leadership Team

Xap Therapeutics

Org chart

Teams

Research and Development

Leadership Team

Offices

Xap Therapeutics

Org chart

Teams

Research and Development

Leadership Team

Offices

Related companies